|
|
||||||||
secretion in hypertensive
and heart failure-prone rats
1 College of Pharmacy;
2 Department of Food Science and
Technology,
Acute increases in blood pressure (BP) increase
myocardial tumor necrosis factor (TNF)-
production, but it is not
known whether chronic hypertensive stress elevates myocardial TNF-
production, possibly contributing to cardiac remodeling, decreased
cardiac function, and faster progression to heart failure. BP, cardiac function, and size were evaluated in normotensive [Sprague-Dawley (SD)], spontaneously hypertensive (SHR), and spontaneously
hypertensive heart failure-prone (SHHF) rats at 6, 12, 15, and 18 mo of
age and in failing SHHF. Left ventricular tissues were evaluated for secretion of bioactive TNF-
and inhibition of TNF-
secretion by
phosphodiesterase inhibitors. All ventricles secreted bioactive and
immunoreactive TNF-
, but secretion decreased with age. SHR and SHHF
rats secreted more TNF-
than SD rats at 6 mo of age, but only
failing SHHF rats secreted significantly more TNF-
at 18 mo.
Amrinone inhibited TNF-
secretion in all rats and was less potent
but more efficacious than RO-201724 in all strains. TNF-
secretion
correlated with BP and left ventricular mass in 6-mo-old rats, but this
relationship disappeared with age. Results suggest that hypertension
and/or cardiac remodeling is associated with elevated myocardial
TNF-
, and, although hypertension, per se, did not maintain elevated
cardiac TNF-
levels, SHHF rats increase TNF-
production during
the end stages of failure.
spontaneously hypertensive rats; SHHF/Mcc-facp rats; phosphodiesterase inhibitors; amrinone; RO-201724
This article has been cited by other articles:
![]() |
P. A. Watson, J. E. B. Reusch, S. A. McCune, L. A. Leinwand, S. W. Luckey, J. P. Konhilas, D. A. Brown, A. J. Chicco, G. C. Sparagna, C. S. Long, et al. Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H246 - H259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. R. Heyen, E. R. Blasi, K. Nikula, R. Rocha, H. A. Daust, G. Frierdich, J. F. Van Vleet, P. De Ciechi, E. G. McMahon, and A. E. Rudolph Structural, functional, and molecular characterization of the SHHF model of heart failure Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1775 - H1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. HUNTER, E. J. STEVENSON, A. KONCAREVIC, H. MITCHELL-FELTON, D. A. ESSIG, and S. C. KANDARIAN Activation of an alternative NF-{kappa}B pathway in skeletal muscle during disuse atrophy FASEB J, April 1, 2002; 16(6): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson, C. K. Kost Jr., W. A. Herzer, G. J. Smits, and S. P. Tofovic A1 Receptor Blockade Induces Natriuresis with a Favorable Renal Hemodynamic Profile in SHHF/Mcc-facp Rats Chronically Treated with Salt and Furosemide J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 978 - 987. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |